ambossIconambossIcon

Aortic regurgitation

Last updated: October 16, 2024

Summarytoggle arrow icon

Aortic regurgitation (AR) is a valvular heart disease characterized by incomplete closure of the aortic valve leading to the reflux of blood from the aorta into the left ventricle (LV) during diastole. Aortic regurgitation can be acute (primarily caused by bacterial endocarditis or aortic dissection) or chronic (e.g., due to a congenital bicuspid valve or rheumatic fever) and may be caused by a valvular defect or an abnormality of the aorta. In most cases, acute AR leads to rapid deterioration of LV function with subsequent pulmonary edema and cardiac decompensation. Chronic AR may remain compensated for a long period of time, becoming symptomatic only when left heart failure develops. Auscultation reveals an S3 and a high-pitched, decrescendo early diastolic murmur. Another characteristic diagnostic finding is widened pulse pressure. Echocardiography is the most important diagnostic tool, both for confirming the diagnosis and determining the severity of disease. In asymptomatic patients, conservative treatment consists of symptom management and physical activity as tolerated. Symptomatic patients or those with severely reduced LV function require surgical intervention, most commonly aortic valve replacement.

Icon of a lock

Register or log in , in order to read the full article.

Etiologytoggle arrow icon

Acute aortic regurgitation [1][2]

Chronic aortic regurgitation [1][3]

Icon of a lock

Register or log in , in order to read the full article.

Classificationtoggle arrow icon

American Heart Association (AHA)/American College of Cardiology (ACC) staging system for chronic AR [5]

Staging is based on echocardiographic criteria and the presence of symptoms.

AHA/ACC staging for chronic aortic valve regurgitation [1]
Stage Definition
Stage A aortic valve regurgitation At risk of AR
Stage B aortic valve regurgitation Progressive AR Mild regurgitation
Moderate regurgitation
Stage C1 aortic valve regurgitation Asymptomatic severe AR (LVEF > 55%)
Stage C2 aortic valve regurgitation Asymptomatic severe AR (LVEF ≤ 55% or LV dilatation > 50 mm)
Stage D aortic valve regurgitation Symptomatic severe AR
Icon of a lock

Register or log in , in order to read the full article.

Pathophysiologytoggle arrow icon

References:[6]

Icon of a lock

Register or log in , in order to read the full article.

Clinical featurestoggle arrow icon

Acute aortic regurgitation [2][7]

Signs and symptoms

Auscultation

Chronic aortic regurgitation [2]

Signs and symptoms

Auscultation

  • S3
  • High-pitched, blowing, decrescendo early diastolic murmur
    • AR due to valvular disease: heard best in the left third and fourth intercostal spaces and along the left sternal border (Erb point)
    • AR due to aortic root disease (e.g., aortic dissection): heard best along the right sternal border
    • Worsens with squatting and handgrip
  • Austin Flint murmur
    • Rumbling, low-pitched, middiastolic or presystolic murmur heard best at the apex
    • Caused by regurgitant blood striking the anterior leaflet of the mitral valve, which leads to premature closure of the mitral leaflets
  • In more severe stages, possibly a harsh, crescendo-decrescendo midsystolic murmur that resembles the ejection murmur heard in aortic stenosis
  • See also “Auscultation in valvular defects.”

Icon of a lock

Register or log in , in order to read the full article.

Diagnosistoggle arrow icon

Approach

Initial evaluation

Echocardiography [5][8]

Other [5]

Additional evaluation [5]

Advanced imaging

Cardiac catheterization

Exercise stress testing

  • Indication: may be used to provoke possible exertional symptoms or assess fitness in patients with severe AR
  • Findings: symptoms of aortic regurgitation (e.g., dyspnea, angina)
Icon of a lock

Register or log in , in order to read the full article.

Treatmenttoggle arrow icon

Approach [2][5]

  • Acute aortic regurgitation
    • Severe acute AR requires surgical treatment as soon as possible. [3][15]
    • Consult cardiology and cardiothoracic surgery immediately.
    • Medical management of complications (e.g., pulmonary edema) should not delay definitive treatment.
    • Identify and treat the underlying cause (see, e.g., “Treatment” in “Infective endocarditis” and “Aortic dissection” articles).
  • Chronic aortic regurgitation
    • Surgery is the mainstay of treatment for symptomatic AR and severe asymptomatic AR.
    • Optimize medical management of comorbidities (e.g., heart failure treatment), especially if surgery is contraindicated.

All patients with acute severe aortic regurgitation should undergo urgent surgical treatment. [2]

IABP increases regurgitated volume and is contraindicated in acute severe AR. [5]

Surgical management [5]

The choice of procedure depends on the cause of the valve defect and comorbidities. All patients with severe aortic regurgitation being considered for intervention should be evaluated by members of a heart valve team if feasible.

Medical management [5]

Acute aortic regurgitation [3][15]

Avoid beta blockers in acute AR, unless due to aortic dissection. [5]

Chronic aortic regurgitation

All patients should be screened and treated for other cardiac risk factors. No medical treatments are known to influence the progression of the disease. [17]

Monitoring [5]

  • Serial echocardiography: Regular follow-up imaging is indicated for asymptomatic patients to identify possible progression and indications for intervention.
    • Mild regurgitation (AR stage B): every 3–5 years
    • Moderate regurgitation (AR stage B): every 1–2 years
    • AR stage C1 regurgitation: every 6–12 months
    • On-demand imaging is indicated for patients with any change in signs or symptoms.
Icon of a lock

Register or log in , in order to read the full article.

Acute management checklisttoggle arrow icon

Icon of a lock

Register or log in , in order to read the full article.

Special patient groupstoggle arrow icon

Icon of a lock

Register or log in , in order to read the full article.

Prognosistoggle arrow icon

  • Asymptomatic patients with normal LVEF: progression to symptoms or LV dysfunction at a rate of < 6% per year [19]
  • Asymptomatic patients with decreased EF: progression to symptoms at a rate of > 25% per year [19]
  • Symptomatic patients: mortality rate is > 10% per year [1][19]
Icon of a lock

Register or log in , in order to read the full article.

Start your trial, and get 5 days of unlimited access to over 1,100 medical articles and 5,000 USMLE and NBME exam-style questions.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer